Ruckdeschel K, Roggenkamp A, Lafont V, Mangeat P, Heesemann J, Rouot B
INSERM U431, Université Montpellier II, France.
Infect Immun. 1997 Nov;65(11):4813-21. doi: 10.1128/iai.65.11.4813-4821.1997.
Suppression of the host defense is one of the hallmarks of Yersinia enterocolitica infection. This enteric pathogen resists phagocytosis and interferes with macrophage functions from an extracellular localization (oxidative-burst generation and tumor necrosis factor alpha production). In this study, we investigated the fate of the Y. enterocolitica-infected macrophage. We found that murine J774A.1 macrophages and macrophages derived from human monocytes were killed by infection with Y. enterocolitica. Analysis of cellular morphology and DNA fragmentation revealed that macrophage cell death occurs through the induction of apoptosis. A total of 92% +/- 5% (mean +/- standard deviation) of murine J774A.1 macrophages and 74% +/- 6% of human monocyte-derived macrophages underwent apoptosis upon Yersinia infection after 4 and 20 h, respectively. The broad-spectrum caspase inhibitor Z-Val-Ala-DL-Asp-fluoromethylketone blocked completion of the Yersinia-induced apoptotic program but not the surface exposure of phosphatidylserine as an early-stage apoptotic event. Analysis of different Yersinia mutants showed that macrophage apoptosis depends on a functional Y. enterocolitica type III protein secretion system. Apoptotic cell death of macrophages was not related to the YopE-mediated cytotoxic effect of Yersinia, since disruption of actin microfilaments by a Y. enterocolitica strain expressing a restricted repertoire of yop genes, including YopE, did not result in macrophage apoptosis. Furthermore, Yersinia-induced cytotoxic alterations in epithelial HeLa cells, which are conferred by YopE, did not lead to apoptosis. Our data demonstrate for the first time that Y. enterocolitica promotes the apoptosis of macrophages, an effect which is clearly distinct from the morphological alterations mediated by Yersinia on epithelial HeLa cells.
宿主防御的抑制是小肠结肠炎耶尔森菌感染的特征之一。这种肠道病原体可抵抗吞噬作用,并从细胞外定位干扰巨噬细胞功能(氧化爆发的产生和肿瘤坏死因子α的产生)。在本研究中,我们调查了感染小肠结肠炎耶尔森菌的巨噬细胞的命运。我们发现,鼠源J774A.1巨噬细胞和源自人单核细胞的巨噬细胞会因感染小肠结肠炎耶尔森菌而死亡。细胞形态和DNA片段化分析表明,巨噬细胞死亡是通过凋亡诱导发生的。在耶尔森菌感染后4小时和20小时,分别有92%±5%(平均值±标准差)的鼠源J774A.1巨噬细胞和74%±6%的人单核细胞衍生巨噬细胞发生凋亡。广谱半胱天冬酶抑制剂Z-Val-Ala-DL-Asp-氟甲基酮可阻断耶尔森菌诱导的凋亡程序的完成,但不能阻断磷脂酰丝氨酸作为早期凋亡事件的表面暴露。对不同耶尔森菌突变体的分析表明,巨噬细胞凋亡取决于功能性小肠结肠炎耶尔森菌III型蛋白分泌系统。巨噬细胞的凋亡性细胞死亡与耶尔森菌的YopE介导的细胞毒性作用无关,因为表达包括YopE在内的有限yop基因库的小肠结肠炎耶尔森菌菌株破坏肌动蛋白微丝不会导致巨噬细胞凋亡。此外,由YopE赋予的耶尔森菌诱导的上皮HeLa细胞的细胞毒性改变不会导致凋亡。我们的数据首次证明,小肠结肠炎耶尔森菌可促进巨噬细胞凋亡,这一效应明显不同于耶尔森菌对上皮HeLa细胞介导的形态学改变。